CHU Besançon ( Site 1358)

Besançon, Franche-Comte 25000

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung

Studies at this site

• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009) — Recruiting now